| Lucille Jeanette Olguin, SLP-MS | |
|
343 Main St Nw, Los Lunas, NM 87031-8712 | |
| (505) 865-9313 | |
| Not Available |
| Full Name | Lucille Jeanette Olguin |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 343 Main St Nw, Los Lunas, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699823161 | NPI | - | NPPES |
| L5889 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1708 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lucille Jeanette Olguin, SLP-MS 179 Tribal Road 2, Bosque Farms, NM 87068-8141 Ph: (505) 869-2698 | Lucille Jeanette Olguin, SLP-MS 343 Main St Nw, Los Lunas, NM 87031-8712 Ph: (505) 865-9313 |
News Archive
"PrePex, a bloodless circumcision device for adults, will be tested in at least nine African countries in the next year, according to the backers of the tests," the New York Times reports.
As the XIX International AIDS Conference convenes in Washington, D.C., Kaiser Family Foundation (KFF) President and CEO Drew Altman highlights positive news about public opinion and HIV from KFF's new survey of the American people conducted with the Washington Post in his latest "Pulling It Together" column.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the latest issue of the peer-reviewed journal, Integrative Cancer Therapies.
SAIC-Frederick Inc., under its prime contract with the National Cancer Institute, has named the Translational Genomics Research Institute (TGen) as one of five national centers selected to conduct cancer experiments using advanced computer simulations.
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.
› Verified 1 days ago
Alisha J Romero-moore, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Romero Road, Los Lunas, NM 87031 Phone: 505-463-1874 | |
Martina Chavez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 436 Peyton Rd, Los Lunas, NM 87031 Phone: 505-710-7106 | |
Lovella C Madrid, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 906 Juan Perea Rd, Los Lunas, NM 87031 Phone: 505-866-7632 | |
Ms. Dora Sandra Gomez, B.A., M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 38 Clarences Rd, Los Lunas, NM 87031 Phone: 505-864-0326 | |
Mrs. Teresa Ann Ogas, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 Wittwer Ct Nw, Los Lunas, NM 87031 Phone: 505-865-9264 | |
Tiffany Chavers, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Marlink, Los Lunas, NM 87031 Phone: 505-865-1750 | |
Jennifer Van Otten, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Colibri Ave Nw, Los Lunas, NM 87031 Phone: 505-865-5301 |